Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | ACUT | Common Stock | 2K | Mar 4, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ACUT | Options (right to buy) | Mar 4, 2022 | Common Stock | 490K | $2.13 | Direct | F1 |
Id | Content |
---|---|
F1 | 49,000 of the options vest on January 25, 2023, 2024 and 2025 and 98,000 vest on January 25, 2026. 122,500 options vest upon the closing of a single equity raise netting not less than $30m for the Company; and 122,500 options vest upon the opening of a commercial CLIA lab in the U.S. no later than the fourth quarter 2023. |